Top compounds associated with response to C2orf50


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.09
mRNA tivozanib GDSC1000 pan-cancer AAC -0.057 0.09
mRNA thapsigargin gCSI pan-cancer AAC -0.094 0.1
mRNA RITA CTRPv2 pan-cancer AAC 0.059 0.1
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.069 0.1
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.053 0.1
mRNA myriocin CTRPv2 pan-cancer AAC -0.13 0.1
mRNA PD-0325901 CCLE pan-cancer AAC -0.069 0.1
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.1
mRNA hyperforin CTRPv2 pan-cancer AAC 0.063 0.1
Download CSV